Law360, Philadelphia (September 07, 2012, 2:27 PM ET) -- A renowned cancer researcher, accused in August of stealing research belonging to his former employer Thomas Jefferson University, agreed to a temporary injunction Thursday giving the school first dibs on patent applications before he publishes any material connected with his work at the school.
During a conference with Philadelphia Court of Common Pleas Judge Gary Glazer, attorneys for researcher Michael Lisanti agreed to give Jefferson two weeks advance notice of any articles or public remarks in order to give the school an opportunity to submit any...
CORRECTED: Jefferson Gets Dibs On Patents From Cancer Doc's Research
To view the full article, take a free trial now.
